Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2016 1
2018 3
2019 1
2020 3
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
miR-205 in Breast Cancer: State of the Art.
Plantamura I, Cataldo A, Cosentino G, Iorio MV. Plantamura I, et al. Among authors: cataldo a. Int J Mol Sci. 2020 Dec 22;22(1):27. doi: 10.3390/ijms22010027. Int J Mol Sci. 2020. PMID: 33375067 Free PMC article. Review.
Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain.
Camelliti S, Le Noci V, Bianchi F, Storti C, Arnaboldi F, Cataldo A, Indino S, Jachetti E, Figini M, Colombo MP, Balsari A, Gagliano N, Tagliabue E, Sfondrini L, Sommariva M. Camelliti S, et al. Among authors: cataldo a. Cancers (Basel). 2021 Aug 13;13(16):4081. doi: 10.3390/cancers13164081. Cancers (Basel). 2021. PMID: 34439233 Free PMC article.
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.
Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El-Abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV. Pizzamiglio S, et al. Among authors: cataldo a. Cancer Med. 2022 Jan;11(2):332-339. doi: 10.1002/cam4.4449. Epub 2021 Dec 17. Cancer Med. 2022. PMID: 34921525 Free PMC article.
13 results